Hospital
Memorial Hospital-West Volusia INC
Memorial Hospital-West Volusia INC was paid $12.65M by Medicaid between Jan 2018 and Dec 2024, across 186 billing codes. Its largest line is 99283, emergency room visit (moderate) — 21% of everything it billed.
33Billing provider infoMEMORIAL HOSPITAL-WEST VOLUSIA INC
DELAND, FL 32720
DELAND, FL 32720
33aNPI1649367269assigned 10/06/2006
33bProvider typePsychiatric Hospital Unit
28Total paid$12.65M
24GClaims453,971
24DCodes billed186
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychiatric Hospital Unit providers in Florida
Rank by total paid#4 of 15
Median peer was paid$7.13M
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,773 | $426K | |
| 2019 | 89,467 | $2.15M | |
| 2020 | 72,744 | $1.75M | |
| 2021 | 90,199 | $2.31M | |
| 2022 | 90,759 | $2.63M | |
| 2023 | 56,971 | $2.20M | |
| 2024incomplete | 24,058 | $1.18M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 33,807 | 31,528 | $2.65M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 24,792 | 22,038 | $1.82M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 7.7% | 5,740 | 5,106 | $977K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.4% | 13,731 | 11,798 | $810K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.1% | 13,721 | 11,902 | $769K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 5.2% | 8,349 | 7,374 | $655K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.0% | 5,674 | 4,877 | $636K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.1% | 5,553 | 5,160 | $397K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.7% | 7,140 | 6,173 | $344K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2.4% | 1,840 | 1,697 | $297K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.0% | 2,691 | 2,347 | $253K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2.0% | 867 | 839 | $251K |
174 more codes
| 80053 | Comprehensive metabolic panel | 1.8% | 29,350 | $231K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.4% | 1,261 | $175K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.4% | 1,073 | $174K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 2,622 | $161K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,057 | $123K |
| 87420 | <1% | 2,160 | $123K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,294 | $121K |
| 71045 | Radiologic examination, chest; single view | <1% | 15,624 | $114K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 7,846 | $92K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,587 | $86K |
| 81025 | <1% | 8,414 | $74K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 7,463 | $71K |
| 81001 | <1% | 13,786 | $61K | |
| 59025 | Fetal non-stress test | <1% | 771 | $58K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 7,959 | $52K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,282 | $48K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,111 | $47K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 705 | $47K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,195 | $43K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 499 | $43K |
| G0378 | Hospital observation service, per hour | <1% | 3,926 | $39K |
| 81003 | <1% | 6,181 | $37K | |
| 82947 | <1% | 6,932 | $36K | |
| 73610 | <1% | 969 | $36K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 794 | $32K |
| 73630 | <1% | 1,154 | $29K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,136 | $29K |
| 87077 | <1% | 2,957 | $28K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,601 | $26K |
| 73130 | <1% | 831 | $26K | |
| 86900 | <1% | 1,051 | $25K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 583 | $24K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 446 | $23K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 32,229 | $22K |
| 01999 | <1% | 1,305 | $20K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 11,610 | $20K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 6,679 | $19K |
| 87186 | <1% | 2,170 | $17K | |
| 84484 | <1% | 8,775 | $17K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 483 | $14K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 677 | $14K |
| 73030 | <1% | 892 | $13K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 441 | $12K |
| 84702 | <1% | 2,046 | $11K | |
| 76377 | <1% | 1,064 | $11K | |
| 72100 | <1% | 917 | $11K | |
| 85610 | <1% | 6,052 | $11K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 9,256 | $10K |
| 73110 | <1% | 434 | $10K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,700 | $10K |
| 76801 | <1% | 1,298 | $10K | |
| 80050 | General health panel | <1% | 386 | $8K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 913 | $8K |
| 73564 | <1% | 338 | $8K | |
| 80061 | Lipid panel | <1% | 2,427 | $8K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 2,061 | $7K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,015 | $7K |
| 96376 | <1% | 1,853 | $6K | |
| 73502 | <1% | 256 | $6K | |
| 93971 | <1% | 392 | $6K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,176 | $6K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,503 | $6K |
| 73562 | <1% | 204 | $6K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,341 | $5K |
| 74018 | <1% | 118 | $5K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,143 | $5K |
| 87070 | <1% | 1,288 | $5K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,533 | $4K |
| 77066 | Tomosynthesis, mammo | <1% | 39 | $4K |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 95 | $4K |
| 87040 | <1% | 2,849 | $4K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 793 | $3K |
| 85730 | <1% | 4,329 | $3K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 689 | $3K |
| 83880 | <1% | 2,346 | $3K | |
| 76642 | <1% | 135 | $3K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 12 | $3K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 75 | $3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 42 | $2K |
| 83605 | <1% | 3,235 | $2K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 398 | $2K |
| J2704 | Injection, propofol, 10 mg | <1% | 440 | $2K |
| 83735 | <1% | 4,777 | $2K | |
| 87210 | <1% | 1,099 | $2K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 164 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,557 | $2K |
| 93970 | <1% | 57 | $2K | |
| 83690 | <1% | 8,052 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,405 | $2K |
| 72040 | <1% | 104 | $2K | |
| 74022 | <1% | 68 | $2K | |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | <1% | 984 | $2K |
| 73080 | <1% | 47 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,666 | $2K |
| 84703 | <1% | 1,404 | $2K | |
| 76830 | Ultrasound, transvaginal | <1% | 233 | $2K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 17 | $1K |
| 97162 | <1% | 31 | $1K | |
| 86850 | <1% | 632 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 433 | $1K |
| 86140 | <1% | 580 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,130 | $1K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 4,849 | $1K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 13 | $1K |
| 94761 | <1% | 319 | $1K | |
| 71250 | <1% | 38 | $985.48 | |
| 71101 | <1% | 29 | $975.45 | |
| 85027 | <1% | 1,263 | $845.75 | |
| 73590 | <1% | 25 | $840.78 | |
| 0001A | <1% | 45 | $827.36 | |
| 73140 | <1% | 12 | $720.24 | |
| 87507 | <1% | 26 | $686.36 | |
| 76857 | <1% | 56 | $680.88 | |
| 0002A | <1% | 44 | $658.64 | |
| G1010 | Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program | <1% | 566 | $633.32 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,278 | $626.24 |
| 85379 | <1% | 1,321 | $619.99 | |
| 82565 | <1% | 1,343 | $515.71 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 58 | $512.66 |
| 82435 | <1% | 762 | $484.72 | |
| 12001 | <1% | 28 | $474.99 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 17 | $466.59 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 715 | $441.05 |
| 82550 | <1% | 524 | $414.88 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 791 | $411.70 |
| 84439 | <1% | 1,125 | $364.33 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 947 | $339.93 |
| 82553 | <1% | 41 | $265.80 | |
| 86901 | <1% | 1,037 | $253.06 | |
| 90715 | <1% | 390 | $250.55 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 703 | $171.12 |
| 82248 | <1% | 32 | $142.68 | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 40 | $135.66 |
| 85014 | <1% | 1,273 | $126.18 | |
| 82077 | <1% | 755 | $122.93 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 12 | $109.48 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 29 | $83.06 |
| 82570 | <1% | 219 | $67.60 | |
| 82607 | <1% | 161 | $53.24 | |
| 80076 | <1% | 34 | $49.48 | |
| 84520 | <1% | 1,009 | $46.70 | |
| 85652 | <1% | 224 | $45.24 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 84 | $42.85 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 376 | $37.76 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 264 | $37.38 |
| 84132 | <1% | 867 | $28.42 | |
| 84295 | <1% | 771 | $18.45 | |
| 82746 | <1% | 15 | $14.83 | |
| 82043 | <1% | 41 | $10.50 | |
| 84466 | <1% | 13 | $3.38 | |
| 84100 | <1% | 120 | $1.56 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 215 | $0.00 |
| 10061 | 0% | 12 | $0.00 | |
| 87076 | 0% | 13 | $0.00 | |
| 85007 | 0% | 31 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 0% | 176 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 18 | $0.00 |
| 80143 | 0% | 223 | $0.00 | |
| 80179 | 0% | 371 | $0.00 | |
| 83540 | 0% | 29 | $0.00 | |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 14 | $0.00 |
| 82010 | 0% | 16 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 191 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 16 | $0.00 |
| 82728 | 0% | 41 | $0.00 | |
| 80051 | 0% | 102 | $0.00 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 0% | 52 | $0.00 |
| 87205 | 0% | 37 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 35 | $0.00 |
| 80047 | 0% | 152 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 52 | $0.00 |
| 86308 | 0% | 13 | $0.00 | |
| 82330 | 0% | 18 | $0.00 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialARMSTRONG, JONATHAN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Memorial Hospital-West Volusia INC | Deland, FL | $330K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.